PharmaEngine, Inc. (TPEX:4162)
Taiwan
· Delayed Price · Currency is TWD 59.30
+1.70 (2.95%)
Mar 10, 2026, 9:39 AM CST
PharmaEngine Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 8,276 | 12,974 | 15,158 | 17,961 | 10,207 | 8,430 | Upgrade
|
| Market Cap Growth | -52.20% | -14.41% | -15.60% | 75.96% | 21.08% | -15.52% | Upgrade
|
| Enterprise Value | 3,688 | 9,241 | 11,619 | 14,348 | 6,496 | 5,058 | Upgrade
|
| Last Close Price | 57.60 | 83.35 | 95.67 | 110.57 | 62.24 | 47.53 | Upgrade
|
| PE Ratio | 4.95 | 7.41 | 55.19 | 56.34 | 23.96 | 13.95 | Upgrade
|
| Forward PE | 21.27 | 10.91 | 42.71 | 150.60 | 38.52 | 109.54 | Upgrade
|
| PS Ratio | 3.30 | 5.14 | 19.75 | 27.45 | 15.59 | 7.98 | Upgrade
|
| PB Ratio | 1.73 | 2.40 | 3.92 | 4.64 | 2.59 | 2.10 | Upgrade
|
| P/TBV Ratio | 1.73 | 2.40 | 3.93 | 4.64 | 2.59 | 2.10 | Upgrade
|
| P/FCF Ratio | 4.81 | 28.46 | 59.08 | 90.45 | 10.98 | 130.16 | Upgrade
|
| P/OCF Ratio | 4.81 | 28.41 | 58.99 | 88.91 | 10.98 | 130.16 | Upgrade
|
| EV/Sales Ratio | 1.47 | 3.66 | 15.14 | 21.93 | 9.92 | 4.79 | Upgrade
|
| EV/EBITDA Ratio | 1.81 | 4.50 | 41.71 | 50.62 | 17.88 | 6.23 | Upgrade
|
| EV/EBIT Ratio | 1.81 | 4.50 | 41.92 | 50.75 | 17.91 | 6.25 | Upgrade
|
| EV/FCF Ratio | 2.14 | 20.27 | 45.29 | 72.26 | 6.99 | 78.09 | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 0.00 | 0.00 | 0.05 | 0.08 | 0.02 | 0.03 | Upgrade
|
| Debt / FCF Ratio | 0.00 | 0.02 | 0.06 | 0.11 | 0.01 | 0.34 | Upgrade
|
| Net Debt / Equity Ratio | -0.96 | -0.71 | -0.93 | -0.94 | -0.97 | -0.84 | Upgrade
|
| Net Debt / EBITDA Ratio | -2.26 | -1.87 | -12.97 | -12.84 | -10.47 | -4.16 | Upgrade
|
| Net Debt / FCF Ratio | -2.67 | -8.45 | -14.08 | -18.33 | -4.09 | -52.06 | Upgrade
|
| Asset Turnover | 0.56 | 0.52 | 0.19 | 0.16 | 0.16 | 0.27 | Upgrade
|
| Inventory Turnover | 3.15 | 2.16 | 1.94 | 2.50 | 2.46 | 1.52 | Upgrade
|
| Quick Ratio | 43.26 | 13.07 | 46.50 | 49.34 | 45.57 | 22.41 | Upgrade
|
| Current Ratio | 43.53 | 13.15 | 46.78 | 49.86 | 45.71 | 22.61 | Upgrade
|
| Return on Equity (ROE) | 38.17% | 37.81% | 7.10% | 8.16% | 10.72% | 16.13% | Upgrade
|
| Return on Assets (ROA) | 28.33% | 26.18% | 4.37% | 4.42% | 5.51% | 12.89% | Upgrade
|
| Return on Invested Capital (ROIC) | - | 185.11% | 93.31% | 125.60% | 73.39% | 175.80% | Upgrade
|
| Return on Capital Employed (ROCE) | 42.40% | 38.00% | 7.20% | 7.30% | 9.20% | 20.10% | Upgrade
|
| Earnings Yield | 20.24% | 13.50% | 1.81% | 1.77% | 4.17% | 7.17% | Upgrade
|
| FCF Yield | 20.77% | 3.51% | 1.69% | 1.11% | 9.11% | 0.77% | Upgrade
|
| Dividend Yield | 9.82% | 7.20% | 1.57% | 1.81% | 4.34% | 5.26% | Upgrade
|
| Payout Ratio | 51.57% | 12.30% | 104.57% | 121.62% | 85.44% | 12.05% | Upgrade
|
| Buyback Yield / Dilution | -0.17% | -0.13% | -0.03% | 0.72% | 0.80% | -0.11% | Upgrade
|
| Total Shareholder Return | 9.65% | 7.07% | 1.54% | 2.53% | 5.13% | 5.14% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.